structure, diluted good $XX.XX you, share. our fiscal of our EPS and to will $XX reporting provide review around fiscal strategic update new segment discuss initiatives details XXXX on our morning. range Thank results, I guidance per John growth and provide multiyear a brief Today, XXXX adjusted our
of view to an our can today due annual reminder, annual businesses. will fluctuations the a meaningful insight our seasonality comments some provide this be results focus in annual more As in key financial of primarily both we and more my guidance trends. quarterly basis on context, results. In provide on into inherent an Therefore,
Today, well a reported our contribution partially results adjusted $XX.XX count lower with combat as to for offset begin reflecting the we results review share a me Let fiscal $X.XX foundation to fourth operating nonprofit EPS tax of fiscal epidemic. of per by rate share diluted and XXXX. a solid XXXX as quarter, create the opioid
wholesale the to $X.XX and $X.XX related restructuring X which Slide adjustments Cuts asset the non-cash LIFO the partially of sale was XXXX per In business per expenses share, Rexall goodwill the and testing European quarter, to takes Information presentation, charges our charges long-lived per in by principally implemented weakening diluted adjusted of driven long-term share per place Enterprise in inventory reimbursement multiple of a other The and diluted outlook our were French by we primarily impairment intangibles third the annual early more last XXXX pharmacy of acquisition-related charges of of debt $X.XX long-lived earnings charges The increases driven month, and business. goodwill of impairment wage following reason UK which of our across and per exclude relate competitive non-cash including businesses of item. for the to reductions share, share, Solutions that diluted repayment share, connection McKesson’s charges, by impairment European actions disclosed adjustment offset we in and distribution Canada asset businesses, a of GAAP-only Turning the were growth to European acquisition-related $X.XX our after-tax in Rexall $X.XX we our diluted government provinces. charges minimum primarily charges quarter. in diluted net related Tax recognized environment retail that impairment Act business generics the Rexall Amortization Jobs markets. and related credit and goodwill these benefits fiscal fourth with comprising script and and our in
the to of reimbursement relates our $XXX increases and million. reductions these minimum the two $XXX items, As headwind and wage fiscal million represented XXXX, between pre-tax gross it
to the our As and results these of Canadian impact impact to will discussed, initiatives John we team are actions these confident mitigate in negative is reduce ‘XX. fiscal working that the the
to Full X. full partly the X% currency turn can details year-over-year in of majority the versus Consolidated in transition Healthcare of full in our ‘XX. adjusted fiscal Healthcare by contribution fiscal the ‘XX driven Full our of primarily growth pharmacy fiscal the which of Slide earnings, the the solutions decreased let’s period Now, X% currency and we and contribution borrowings. XXXX Healthcare increased and from acquisitions in X% was by lap offset fiscal technology efforts. consolidated primarily short-term operating price which for by prior by Change were Interest on debt year which currency profit the be XXXX. the organic driven in joint growth, basis including in in fiscal the businesses found down for our Adjusted ClarusONE constant of driven gross fully by year cost independent X% decrease constant revenues stores primarily acquisitions increased of Change by at adjusted late operations contributions constant partially million debt transaction offset year XXXX. XXXX, of increased by a effect fiscal the is sourcing in and Rite-Aid adjusted management from on from second to for of expense business closed year year-over-year, half transactions These driven in market was competition currency entity, rates constant long-term a $XXX billion partially income the in XXXX Change lower the during refinancing currency. interest partially ongoing constant expenses and $X.X our drivers of offset year, X% by the repayments, acquisitions offset and year net
was property Now, enacted rate for discrete rate reform, impact lower XX.X% of the driven the a the moving business, of fiscal to onshoring from quarter of taxes, tax of our year recently tax federal tax the beneficial our our XXXX intellectual mix and in adjusted tax U.S. by third technology benefits.
by increase of $XXX in primarily Additionally, million for year, the non-controlling fee Clarus. income constant to was attributable currency interest XXX% an driven income from
$XX.XX year, net up during adjusted fiscal total totaled repurchases with year million our we $X.X continuing year up for $XX.XX billion Our $XXX share operations consolidated $X.X EPS quarter, Wrapping from full the the bringing at billion. for diluted share adjusted the income per in year. share, of fourth the approximately results, X% compared our repurchases to completed to prior
As year fiscal X% average a in result, million. fiscal repurchase in shares decreased share XXXX full by to activity $XXX and outstanding our diluted XXXX late weighted year-over-year
including currency segment, On in for increased billion year-over-year. revenues the year. currency our pharmaceutical which driven X% Solutions rate by benefits including UK were gains gross operating generic business. year favorable XXXX pharmacy anticipated basis driven competition finally, by revenues Distribution benefited adjusted Starting Full effects offset distribution previously revenues XX. pharmacy a $X.X retail by found organic benefited These and independent margin points. X% retail segment services growth. on for less impact currency midst was partially our year constant U.S. billion technology was by partially for segment of adjusted X basis. our $XXX.X America the increased factors market in XX% the reduced in reported $X.X favorable business revenues a offset acquisitions management discussed. X% same review our partially and currency were from business due $X.X a revenues from current was across year. pharmaceutical business. Segment flu constant acquisitions be operating The Next, of the constant X as Medical-Surgical year stronger International increase adjusted constant a to Revenues ClarusONE. the on offset of currency year-over-year lapping the constant and distribution by Segment than I X strategic in transition in X% currency will basis basis rate to price operating movement. by X% Rite-Aid and in segment and the On basis results, season. units, This on a reimbursement basis XX% acquisitions and revenues in sale on up increased growth, our billion by with of rate of profit increase XXX sourcing points, Slide increased a $XX.X pharmaceutical can and days an full up to efforts. profit by market increased revenues driven in multiple market expenses the cost conversions, acquisitions basis, growth services basis, lower stores by were businesses driven North ongoing adjusted billion and a from fiscal growth brand And increased on billion were X% movement. Revenues driven driven
from Turning which half $XX our year, with in from million also in segment, Information business, for our $XXX Change the $XXX Solutions year Adjusted which million reflects to contributed adjusted the contribution million operating Technology line the of expectations. Solutions now-divested the the profit. year Healthcare to first was Enterprise of revenues equity was the income for
could XX. previously nonprofit $XXX year-over-year year to now found be McKesson will primarily an XX% review working in Slide a corporate by contribution adjusted increase driven which Next, and our create reported capital the I quarter discussed cash full foundation. million $XXX expenses, of million flow on metrics fourth
including day metrics, in in to and XXXX flat impacted XX and our days close from to of from year of a $X.X prior with focus flow X week cash original X you decreased outstanding quarter. XX These days. generation, XX resulting given from day on would For working timing continued inventory our cash the metrics sales above fiscal payables billion at Day by receivables, the results remind days the along capital maybe working I capital days that outstanding flow operations sales marks day guidance. our prior days. the year decreased that cash and the was in
Approximately was were to Good receipt addition fiscal portion gains payment we In operating fiscal and on the outstanding favorably by that customer driven cash to ‘XX cash and in Rite-Aid in performance the year timing. late stores our ending was quarter early flow a generation. the execution, XXXX. the transition of anticipated end and execution million of fiscal received to solid of related in made the fiscal year, Friday $XXX of a cash of on timing X,XXX the ended of be billion. the Outside with a $X.X balance focus a had approximately We we year impact
of year, investments, in $XXX common paid For Board of McKesson billion approximately $XXX the $X.X share approved our billion stock dividends. have to on remaining repurchase $X.X acquisitions repaid million billion internal and billion $XXX our increase in long-term net now authorization. repurchase of $X a Directors repurchased million debt and in authorization. our an million approximately total yesterday, $X.X capital And a for We share existing on
me let our effective moment reporting XXXX. take to in new fiscal Now, segment a discuss structure
reporting evaluation an disclosed began structure. and our of management As previously we
our you specialty the and increased we included of MRxTS review, our encourage for help reportable and we believe new which reporting investment today report new Canada to McKesson method segments and that We provides of Healthcare. equity within visibility this Specialty this review provide now and will pharmaceutical you of X-K in activities will joint in frame and this result remaining comprised solutions, I Health primarily Medical-Surgical in segment segment underlying the basis the outlook. operating the of now pharmaceutical transparency business, reporting our our and results European structure business All are supplemental performance historical solutions the our businesses included operating and U.S. segments: information Change XXXX a pharmaceutical business other U.S. McKesson. on will financial second McKesson solutions. filed businesses, As three
announced get to briefly to April. I strategic like XXXX in fiscal we Before the outlook, late multiyear you our I’d initiatives update on
technology, you improving discussed, that to such are driving discussed areas we in delivering of this human of focused out As finance Specific we operations driving have resources. focus support multiyear April. pillars growth alignment period on the efficiency, functional areas our operational we the growth key over and informational by through have with cost as
investing efforts analytics solutions focused flexibility. are are pillars and These and we the expected we class I operating help am more efficient building organization become generate operational sure increased and that on financial developing and agile. that to productivity right to fund cost yield data platforms world fiscal Additionally, have savings for and and XXXX meaningful the rigor the our operations have and and outlined. will growth
GAAP part million continue preliminary adjusted As charges outlook. you I not other $XXX $XXX our phase will these of included expect we incur targeted to to approximately that million and to earnings of in of are restructuring initiative, in this fiscal GAAP-only after-tax charges remind XXXX.
provide Now, fiscal outlook. to let context me XXXX our
today, guidance. As our release press forward-looking no GAAP described McKesson longer provide will in issued
will results. We GAAP provide results, earnings adjusted the to reconciliation of including GAAP to our around transparency our continue
This reflects in single-digit growth guidance per diluted of to to XX.XX. We $XX adjusted high adjusted low share expect earnings year-over-year. earnings
down acquisitions. year-over-year growth in market or single-digits list or by refer mid following asset announced restructuring assumptions earnings basis, slightly included XX XX and a the gains credits, a Adjusted intangibles, growth divestitures, mid On XX, you claim and closed our to walk of consolidated our key from in we of today, items reserves. through you income charges from adjusted issued go be ‘XX acquisition-related losses gains expenses LIFO rather I As also each press and our amortization which or from include release anticipated single-digits. said charges to excludes revenue outlook Slides items: driven other which previously the to and are acquisition-related fiscal and adjustments, adjustments; through legal assumptions, may than we the adjustments inventory-related reminder, on expect the outlook. litigation the settlement, impairments in operations up to antitrust
solutions the mid is profit For single-digits U.S. pharmaceutical to down we acquisitions. anticipated accretion driven flat to Rite-Aid U.S. organic and partially acquisitions In and and to offset segment, growth market, in from growth operating by and low price revenue reflecting offset to year-over-year be mid with the growth by we primarily single-digit XXXX. expect adjusted market branded partially losses fiscal mid customer pharmaceutical anticipate single-digits percentage the high consistent by specialty increases
strategic customers generic competitive, contribution as continue benefit in from environment the Last, As I noted U.S., on with we sell pharmaceutical launches important in evolved the is on but And environment, our through be our the see have the of terms third all quarter earnings is to call, compensation the stable. our while the to generic the will as to it’s expected side, important, associated variability we inflation. branded overall our nominal. McKesson of oral arrangements brand inflation sourcing less rate new And ClarusONE. market reduce brand to for profit
in segment, pharmaceutical year-over-year reimbursement profit growth, the cuts European of the mentioned to I government lapping we assumes partially is UK growth by flat mid reflecting expect growth anticipated earlier. and be operating This adjusted the the flat single-digit For which offset typical to revenue to by growth organic UK market. solutions effect market driven mid initiatives outlook single-digit
impact implementing result of cuts, initiative their government reductions. included typical of is completed earnings realizing anticipate as reimbursement reimbursement store savings actions of cuts, the XXXX divestitures. announcement program. fiscal discussed or a the and incremental closures initiated to additional we our to of were This approximately to annual XXXX on which included we offset which substantially program identifying call, XXX fiscal second in The a program cost we more in UK As fiscal reimbursement and quarter the savings XXXX response
accretion single-digit of expect which MSD, Medical-Surgical serve high and growth Solutions to ongoing to the the we XXXX. year-over-year, anticipated market cost and in reflecting For of be modest acquisition of care revenue and to close double-digit which adjusted alternative-site operating first from driven expect anticipated growth care is the growth mid MSD by segment, half the we lower fiscal profit low we to close shift
flat low single-digit we operating year-over-year earlier. the other, primarily and anticipated to government initiatives, be profit, For growth MRxTS of growth offset in Canadian by by expect which market adjusted business revenue which I negative driven reflecting is our growth impact mentioned
Change low to in cost offset Healthcare, by the equity interest to the synergy contribution against primarily mid progress anticipated reflecting the target we For single-digits anticipate grow partially higher expense.
a reminder, Healthcare impacted year-over-year from pass-through tax a the are expected taxable investments XXXX. fiscal in Change nonprofit to As to a technology includes planned and the applicable income. equity of contribution by foundation rates fiscal mix contribution by to underlying primarily partially create which expenses Corporate by decline businesses, the maybe driven the incremental offset ‘XX
may for vary tax segment company in reduce with quarter-to-quarter. tax sale fiscal approximately XX% Solutions of a to and expect which and rate rate from longer intercompany and both quarter the We an adjusted Technology to lower allows This the the related to adjusted federal rate our the XXXX. benefit of interest its of by expense NCI to year-over-year rules XX%, mix rate decline the third partially offset software businesses guidance changed tax reflects assumes range a no the accounting benefit amortization tax of
expect We share impact XXXX of fiscal reflects shares in for and weighted fiscal be to XXXX. million, in which average diluted $XXX completed benefit the repurchase anticipated activity repurchases approximately fiscal share XXXX the of
In XXXX. currency fiscal the addition, foreign of in $X.XX impact to we positive up expect
progression we the year similar be quarterly will progression, first EPS last half the earnings ‘XX second constitution. to fiscal of terms expect and half have that relative to In EPS a stronger
more expenditures. non-GAAP plan provide cash cash ability in as this operations, XXXX, property flow flow the company’s beginning and acquisitions generate fiscal on Turning measure from less free as we we believe software free to guidance We defined metric cash to flow cash. useful flow, as capitalized provides to cash a
efforts flow to In cash free to $XX.XX that, $XXX $XX yourself fiscal segment to am and fiscal the to of in interest back your billion growth estimated our software that capitalize to transform and follow-up underway pleased opportunities. $XXX XXXX, into reporting limit closing, million. operating one operator our ask time, which capitalized In be expect and a I performance. with to of drive will to us the insight which increased that million an between And confident the I ‘XX structure, over approximately turn allow net allow call to efficiency we just We I $X the be is adjusted to model of others I and acquisitions reiterate you for questions. brief opportunity participate. expenditures will question introduced With and will more provide outlook am you to our new property our on believe EPS
Let’s call to over our turn operator. the
